Cookie consent

We use cookies to improve your experience on this website. By continuing to browse our site you agree to our use of cookies. Tell me more | Cookie preferences

Pfizer defends its bid for AstraZeneca

(FILES) - A file picture taken on October 20, 2009 shows a sign for pharmaceutical company Pfizer Incorporated headquarters in New York. The US pharmaceutical company Pfizer, which plans to further raise its staggering offer to buy its British rival AstraZeneca, is faced with a rising political pressure on both sides of the Atlantic. CEO Ian Read is preparing to fly to Britain where he will be heard on May 13, 2014 by British lawmakers worried the social impact of this potential marriage to more than 100 billion dollars. AFP PHOTO / TIMOTHY A. CLARYTIMOTHY A. CLARY/AFP/Getty Images

    Just Watched

    Pfizer defends its bid for AstraZeneca

Without even a formal bid, Pfizer's plan to buy AstraZeneca has upset politicians of all stripes. Jim Boulden reports.